Suppr超能文献

相似文献

1
Role of domain interactions in the aggregation of full-length immunoglobulin light chains.
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):854-863. doi: 10.1073/pnas.1817538116. Epub 2018 Dec 31.
3
The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.
J Mol Biol. 2018 Dec 7;430(24):4925-4940. doi: 10.1016/j.jmb.2018.10.024. Epub 2018 Nov 8.
4
Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants.
J Mol Biol. 2020 Nov 20;432(23):6187-6199. doi: 10.1016/j.jmb.2020.10.005. Epub 2020 Oct 13.
6
Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
FEBS J. 2017 Sep;284(18):3114-3127. doi: 10.1111/febs.14181. Epub 2017 Aug 13.
7
The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.
J Mol Biol. 2015 Nov 6;427(22):3572-3586. doi: 10.1016/j.jmb.2015.09.012. Epub 2015 Sep 25.
9
10
A role for destabilizing amino acid replacements in light-chain amyloidosis.
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5446-50. doi: 10.1073/pnas.91.12.5446.

引用本文的文献

1
Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.
Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.
3
A conformational fingerprint for amyloidogenic light chains.
Elife. 2025 Mar 3;13:RP102002. doi: 10.7554/eLife.102002.
4
Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.
Protein J. 2025 Feb;44(1):1-20. doi: 10.1007/s10930-024-10237-6. Epub 2024 Nov 11.
7
Pharmacological stabilization of the native state of full-length immunoglobulin light chains to treat light chain amyloidosis.
Curr Opin Chem Biol. 2023 Aug;75:102319. doi: 10.1016/j.cbpa.2023.102319. Epub 2023 Jun 6.
8
Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains.
Amyloid. 2023 Dec;30(4):364-378. doi: 10.1080/13506129.2023.2212397. Epub 2023 May 22.
9
Complete variable domain sequences of monoclonal antibody light chains identified from untargeted RNA sequencing data.
Front Immunol. 2023 Apr 18;14:1167235. doi: 10.3389/fimmu.2023.1167235. eCollection 2023.
10
Producing amyloid fibrils in vitro: A tool for studying AL amyloidosis.
Biochem Biophys Rep. 2023 Feb 24;34:101442. doi: 10.1016/j.bbrep.2023.101442. eCollection 2023 Jul.

本文引用的文献

1
Light Chain Amyloidosis.
Mediterr J Hematol Infect Dis. 2018 Mar 1;10(1):e2018022. doi: 10.4084/MJHID.2018.022. eCollection 2018.
3
Transthyretin Cardiac Amyloidosis.
Curr Cardiol Rep. 2017 Aug 24;19(10):97. doi: 10.1007/s11886-017-0911-5.
4
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115. Epub 2017 May 12.
5
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.
J Am Coll Cardiol. 2016 Sep 20;68(12):1323-41. doi: 10.1016/j.jacc.2016.06.053.
8
Type 2 diabetes as a protein misfolding disease.
Trends Mol Med. 2015 Jul;21(7):439-49. doi: 10.1016/j.molmed.2015.04.005. Epub 2015 May 18.
9
Formation of amyloid fibers by monomeric light chain variable domains.
J Biol Chem. 2014 Oct 3;289(40):27513-25. doi: 10.1074/jbc.M114.585638. Epub 2014 Aug 19.
10
Clustal Omega, accurate alignment of very large numbers of sequences.
Methods Mol Biol. 2014;1079:105-16. doi: 10.1007/978-1-62703-646-7_6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验